BioCentury | Feb 12, 2020
Politics, Policy & Law

When single-payer systems adopt innovation better than U.S. commercial payers

...and visionary initiative created and pulled through by founder and chief innovation officer, Clive Meanwell, MedCo...
...shouldn’t be making cost-effectiveness decisions before it is ready to act on them. Meanwell and MedCo...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...at Express Scripts Holding Co. (NASDAQ:ESRX) and market group CFO/VP - national accounts group at Medco Health Solutions Inc. Hongjiang...
BioCentury | Sep 7, 2015
Strategy

Back to School 2015: Changing the subject

...better outcomes. "A payer would want to see data," said Robert Epstein, former CMO at Medco Health Solutions Inc....
BioCentury | Feb 23, 2015
Company News

AstraZeneca pl pharmaceuticals news

...U.S. government $7.9 million to settle allegations that it engaged in a kickback scheme with Medco Health Solutions Inc....
...violation of the False Claims Act. Express Scripts Holding Co. (NASDAQ:ESRX, St. Louis, Mo.) acquired Medco...
BioCentury | Sep 2, 2013
Strategy

Back to School 2013: Facing reality

For the first time since the 2008 meltdown, nearly everything appears to be coming up roses for biopharma. Money is again flowing into the sector, FDA , EMA and Japan's Pharmaceuticals and Medical Devices Agency are...
BioCentury | Jul 15, 2013
Company News

Vivus endocrine/metabolic news

...it amended its agreements with Express Scripts Holding Co. (NASDAQ:ESRX, St. Louis, Mo.) and Express' Medco Health Solutions Inc....
...where Qsymia is offered on Tier 2 will have a co-pay of $25-$30 per month. Medco...
BioCentury | May 27, 2013
Clinical News

Gattex regulatory update

...Cigna Corp. (NYSE:CI, Bloomfield, Conn.), Express Scripts Holding Co .(NASDAQ:ESRX, St. Louis, Mo.), Express Scripts' Medco Health Solutions Inc....
BioCentury | May 20, 2013
Company News

Vivus, Express Scripts sales and marketing update

...Vivus said obesity drug Qsymia phentermine/topiramate was added to the national formulary for Express Scripts' Medco Health Solutions Inc....
BioCentury | Apr 15, 2013
Company News

Medco, University of Ferrara deal

...which develops cardiovascular medicines and adenosine-based products, will own intellectual property derived from the collaboration. Medco...
BioCentury | Jan 7, 2013
Company News

Valeant Pharmaceuticals management update

...and an EVP, effective Feb. 1, formerly SVP of consumer solutions and retail markets at Medco Health Solutions Inc....
Items per page:
1 - 10 of 170
BioCentury | Feb 12, 2020
Politics, Policy & Law

When single-payer systems adopt innovation better than U.S. commercial payers

...and visionary initiative created and pulled through by founder and chief innovation officer, Clive Meanwell, MedCo...
...shouldn’t be making cost-effectiveness decisions before it is ready to act on them. Meanwell and MedCo...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...at Express Scripts Holding Co. (NASDAQ:ESRX) and market group CFO/VP - national accounts group at Medco Health Solutions Inc. Hongjiang...
BioCentury | Sep 7, 2015
Strategy

Back to School 2015: Changing the subject

...better outcomes. "A payer would want to see data," said Robert Epstein, former CMO at Medco Health Solutions Inc....
BioCentury | Feb 23, 2015
Company News

AstraZeneca pl pharmaceuticals news

...U.S. government $7.9 million to settle allegations that it engaged in a kickback scheme with Medco Health Solutions Inc....
...violation of the False Claims Act. Express Scripts Holding Co. (NASDAQ:ESRX, St. Louis, Mo.) acquired Medco...
BioCentury | Sep 2, 2013
Strategy

Back to School 2013: Facing reality

For the first time since the 2008 meltdown, nearly everything appears to be coming up roses for biopharma. Money is again flowing into the sector, FDA , EMA and Japan's Pharmaceuticals and Medical Devices Agency are...
BioCentury | Jul 15, 2013
Company News

Vivus endocrine/metabolic news

...it amended its agreements with Express Scripts Holding Co. (NASDAQ:ESRX, St. Louis, Mo.) and Express' Medco Health Solutions Inc....
...where Qsymia is offered on Tier 2 will have a co-pay of $25-$30 per month. Medco...
BioCentury | May 27, 2013
Clinical News

Gattex regulatory update

...Cigna Corp. (NYSE:CI, Bloomfield, Conn.), Express Scripts Holding Co .(NASDAQ:ESRX, St. Louis, Mo.), Express Scripts' Medco Health Solutions Inc....
BioCentury | May 20, 2013
Company News

Vivus, Express Scripts sales and marketing update

...Vivus said obesity drug Qsymia phentermine/topiramate was added to the national formulary for Express Scripts' Medco Health Solutions Inc....
BioCentury | Apr 15, 2013
Company News

Medco, University of Ferrara deal

...which develops cardiovascular medicines and adenosine-based products, will own intellectual property derived from the collaboration. Medco...
BioCentury | Jan 7, 2013
Company News

Valeant Pharmaceuticals management update

...and an EVP, effective Feb. 1, formerly SVP of consumer solutions and retail markets at Medco Health Solutions Inc....
Items per page:
1 - 10 of 170